RESUMEN
For a series of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV ADME properties were improved by the incorporation of amide replacements. These efforts led to a novel series of potent and selective inhibitors of DPP-4 that exhibit an attractive pharmacokinetic profile and show excellent efficacy in an animal model of diabetes.
Asunto(s)
Amidas/química , Aminobutiratos/química , Inhibidores de la Dipeptidil-Peptidasa IV , Relación Estructura-Actividad , Amidas/antagonistas & inhibidores , Células CACO-2 , Línea Celular Tumoral , Química Farmacéutica , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Inhibidores de la Dipeptidil-Peptidasa IV/uso terapéutico , Diseño de Fármacos , Humanos , Hipoglucemiantes/antagonistas & inhibidores , Hipoglucemiantes/uso terapéutico , Inhibidores de Proteasas/farmacocinética , Inhibidores de Proteasas/farmacología , Canales de Sodio/metabolismoRESUMEN
A series of highly potent and selective inhibitors of DPP-4 was optimized for ADMET properties. The effort resulted in the discovery of inhibitor 1g, that exhibits excellent efficacy in an oral glucose tolerance test and an attractive pharmacokinetic profile.
Asunto(s)
Aminobutiratos/química , Inhibidores de la Dipeptidil-Peptidasa IV , Hidrocarburos Fluorados/química , Hipoglucemiantes/química , Inhibidores de Proteasas/química , Pirrolidinas/química , Administración Oral , Aminobutiratos/síntesis química , Aminobutiratos/farmacocinética , Animales , Células CACO-2 , Línea Celular Tumoral , Dipeptidil Peptidasa 4/metabolismo , Perros , Humanos , Hidrocarburos Fluorados/síntesis química , Hidrocarburos Fluorados/farmacología , Hipoglucemiantes/síntesis química , Hipoglucemiantes/farmacocinética , Inhibidores de Proteasas/síntesis química , Inhibidores de Proteasas/farmacocinética , Pirrolidinas/síntesis química , Pirrolidinas/farmacología , Ratas , Relación Estructura-ActividadRESUMEN
Modifications of DPP-4 inhibitor 5, that was discovered by structure based design, are described and structure-activity relationships discussed. With analogue 7k one of the most potent non-covalent inhibitors of DPP-4 reported to date (IC(50)=0.38nM) was discovered. X-ray structure of inhibitor 7k bound to DPP-4 revealed a hydrogen bonding interaction with Q553. First successful efforts in balancing overall properties, as demonstrated by improved metabolic stability, highlight the potential of this series.
Asunto(s)
Amidas/síntesis química , Aminobutiratos/química , Inhibidores de la Dipeptidil-Peptidasa IV , Inhibidores de la Dipeptidil-Peptidasa IV/síntesis química , Microsomas Hepáticos/efectos de los fármacos , Sulfonamidas/síntesis química , Amidas/farmacología , Animales , Química Farmacéutica/métodos , Cristalografía por Rayos X/métodos , Inhibidores de la Dipeptidil-Peptidasa IV/farmacología , Diseño de Fármacos , Péptido 1 Similar al Glucagón/antagonistas & inhibidores , Enlace de Hidrógeno , Concentración 50 Inhibidora , Microsomas Hepáticos/metabolismo , Ratas , Relación Estructura-Actividad , Sulfonamidas/farmacologíaRESUMEN
The underlying frameworks of natural product classes with multiple biological activities can be regarded as biologically selected and prevalidated starting points in vast chemical structure space in the development of compound collections for chemical biology and medicinal chemistry research. For the synthesis of natural product-derived and -inspired compound collections, the development of enantioselective transformations in a format amenable to library synthesis, e.g., on the solid support, is a major and largely unexplored goal. We report on the enantioselective solid-phase synthesis of a natural product-inspired alpha,beta-unsaturated delta-lactone collection and its investigation in cell-based screens monitoring cell cycle progression and viral entry into cells. The screens identified modulators of both biological processes at a high hit rate. The screen for inhibition of viral entry opens up avenues of research for the identification of compounds with antiviral activity.
Asunto(s)
Productos Biológicos/química , Ciclo Celular/efectos de los fármacos , Lactonas/química , Lactonas/farmacología , Internalización del Virus/efectos de los fármacos , Animales , Sitios de Unión , Productos Biológicos/metabolismo , Línea Celular , Cercopithecus , Técnicas Químicas Combinatorias , Diseño de Fármacos , Células HeLa , Humanos , Lactonas/síntesis química , Lactonas/metabolismo , Conformación Molecular , Unión Proteica , Estereoisomerismo , Virus de la Estomatitis Vesicular IndianaRESUMEN
The first total synthesis of aquatic peptide microcin SF608 is described. Coupling of L-Hpla with the dipeptide L-Phe-L-Choi followed by coupling with agmatine and a deprotection step gave microcin SF608. In addition, the levorotatory character of L-Hpla (5) was thoroughly established, and the conformational analysis of L-Choi containing peptides 1 and 8-10 was performed using NMR spectroscopy to examine the cis-trans isomer equilibrium of the L-Phe-L-Choi amide bond.